Evidence map›Paper›PMID 37438530›Full record

ArticleNature2023

PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection.

Dijin Xu, Weiqian Jiang, Lizhen Wu, Ryan G Gaudet, Eui-Soon Park, Maohan Su, Sudheer Kumar Cheppali, Nagarjuna R Cheemarla, Pradeep Kumar, Pradeep D Uchil and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
24.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 93 citations in OpenAlex.

  1. Plscr1 inhibits murine norovirus entry.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. METTL7A-Dependent mMedComm · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. IFN-inducible human phospholipid scramblase 1 (PLSCR1) protein restricts HIV-1 infection by inhibiting membrane fusion.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 4 countries.

Dijin Xu *Howard Hughes Medical Institute, New Haven, CT, USA.ORCID 0000-0001-7955-4855
Weiqian Jiang *Howard Hughes Medical Institute, New Haven, CT, USA.
Lizhen WuDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Ryan G GaudetHoward Hughes Medical Institute, New Haven, CT, USA.
Eui-Soon ParkHoward Hughes Medical Institute, New Haven, CT, USA.ORCID 0000-0002-1375-8027
Maohan SuDepartment of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5523-9607
Sudheer Kumar CheppaliYale Nanobiology Institute, West Haven, CT, USA.ORCID 0000-0002-2282-4882
Nagarjuna R CheemarlaDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-8860-2457
Pradeep KumarHoward Hughes Medical Institute, New Haven, CT, USA.
Pradeep D UchilDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-7236-858X
Jonathan R GroverDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.
Ellen F FoxmanDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-9767-9942
Chelsea M BrownSchool of Life Sciences and Department of Chemistry, University of Warwick, Coventry, UK.ORCID 0000-0003-2006-5015
Phillip J StansfeldSchool of Life Sciences and Department of Chemistry, University of Warwick, Coventry, UK.ORCID 0000-0001-8800-7669
Joerg BewersdorfDepartment of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-4085-7020
Walther MothesDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-3367-7240
Erdem KaratekinYale Nanobiology Institute, West Haven, CT, USA.ORCID 0000-0002-5934-8728
Craig B WilenDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-2495-9403
John D MacMickingHoward Hughes Medical Institute, New Haven, CT, USA. john.macmicking@yale.edu.ORCID 0000-0002-1734-135X
Yale University · USHoward Hughes Medical Institute · USUniversity of Warwick · GB

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Structure and Dynamics of the SARS-CoV-2 Spike ProteinR01AI163395 · NIAID · YALE UNIVERSITY · PI MOTHES, WALTHER H · 2021 to 2025
$4.1M
Nucleation and dynamics of exocytotic fusion poresR01NS113236 · NINDS · YALE UNIVERSITY · PI KARATEKIN, ERDEM · 2019 to 2023
$1.8M
Medical Research Council MR/S009213/1NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI163395NINDS NIH HHS R01 NS113236Wellcome Trust
6 · The paper itself

Abstract

Understanding protective immunity to COVID-19 facilitates preparedness for future pandemics and combats new SARS-CoV-2 variants emerging in the human population. Neutralizing antibodies have been widely studied; however, on the basis of large-scale exome sequencing of protected versus severely ill patients with COVID-19, local cell-autonomous defence is also crucial

Indexed as

COVID-19Phospholipid Transfer ProteinsSARS-CoV-2AnimalsAntibodies, NeutralizingAntibodies, ViralChiropteraExome SequencingHepatocytesHumansInterferon-gammaLungMembrane FusionMiceVirus InternalizationAntibodies, NeutralizingAntibodies, ViralInterferon-gammaPhospholipid Transfer ProteinsPLSCR1 protein, humanPlscr1 protein, mouse

Identifiers

PMID37438530
PMCPMC10371867
OpenAlexW4384024945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.